Skip to main content

Eledon Pharmaceuticals, Inc. (ELDN) Stock

Eledon Pharmaceuticals, Inc. Stock Details, Movements and Public Alerts

Stock Details

Eledon Pharmaceuticals, Inc. (ELDN), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $2.76. Over the past 52 weeks, it has ranged between $1.35 and $4.60. This places the current price at 60.0% of its 52-week high and 104.4% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 65.05, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $2.16 by 27.78%. Similarly, it is above its 200-day moving average of $2.58 by 6.98%. The MACD histogram is 0.04, indicating bullish momentum (MACD Line: 0.19, Signal Line: 0.16).

52-Week Range

$4.60 - $1.35

-40.00% from high · +104.44% from low

Avg Daily Volume

1,075,220

20-day average

100-day avg: 1,666,293

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-2.93

Price to Book

1.82

EPS (TTM)

-$1.24

Beta

0.96

Less volatile than market

Q:How is ELDN valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is ELDN's risk profile compared to the market?
With a beta of 0.96, Eledon Pharmaceuticals, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.82 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

Return on Equity

-95.49%

Return on Assets

-44.22%

Q:How profitable and efficient is ELDN's business model?
Profitability metrics are not available for this stock.
Q:What are ELDN's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$219.8M

Shares Outstanding

79.63M

Book Value/Share

$1.52

Asset Type

EQUITY

Q:What is ELDN's market capitalization and position?
Eledon Pharmaceuticals, Inc. has a market capitalization of $219.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 79.63M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does ELDN's price compare to its book value?
Eledon Pharmaceuticals, Inc.'s book value per share is $1.52, while the current stock price is $2.76, resulting in a price-to-book (P/B) ratio of 1.82. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$8.00

189.86% upside potential

Analyst Recommendations

Strong Buy

0

Buy

7

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for ELDN?
7 analysts cover ELDN with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $8.00 implies 189.9% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on ELDN?
Current analyst recommendations:07 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 12, 2026, 02:06 AM

Technical Indicators

RSI (14-day)

65.05

Neutral

50-Day Moving Average

$2.16

27.78% above MA-50

200-Day Moving Average

$2.58

6.98% above MA-200

MACD Line

0.19

MACD Signal

0.16

MACD Histogram

0.04

Bullish

Q:What does ELDN's RSI value tell investors?
The RSI (Relative Strength Index) for ELDN is currently 65.05, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret ELDN's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.19 above the signal line at 0.16, with histogram at 0.04. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($2.16) is below the 200-day MA ($2.58), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 12, 2026, 12:51 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for ELDN and get notified when the price changes.

Stay Ahead of the Market with Eledon Pharmaceuticals, Inc. Alerts

Set up price alerts for Eledon Pharmaceuticals, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.